Malignant Triton Tumor of the Kidney. New Location Not Previously Reported

Area of Science:

• Oncology
• Pathology
• Neurosurgery

Background:

• Malignant triton tumor (MTT) is a rare, aggressive variant of peripheral nerve sheath tumors.
• MTT exhibits limited survival rates and often presents with neurofibromatosis type 1 symptoms.
• No standardized treatment exists, necessitating a multimodal therapeutic approach.

Observation:

• A primary malignant triton tumor was identified in the kidney of a 43-year-old female patient.
• The patient's tumor was initially treated with neoadjuvant chemotherapy.
• This was followed by surgical resection and subsequent adjuvant chemotherapy.

Findings:

• The case demonstrates a successful primary kidney MTT treatment protocol.
• Neoadjuvant chemotherapy as a first-line treatment was effective in managing the aggressive tumor.
• A multimodal approach involving chemotherapy and surgery yielded positive outcomes.

Implications:

• This case contributes to understanding the management of rare renal malignancies.
• It suggests neoadjuvant chemotherapy can be a viable first-line strategy for primary kidney MTT.
• The findings support the efficacy of multimodal therapy in improving survival for aggressive MTT cases.